Drug Trial Radar · NCT06752668
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
248
Planned (sponsor's estimate)
Start
Dec 23, 2024
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Centessa Pharmaceuticals (UK) LimitedIndustry
- Sponsor type
- Industry
- First posted
- Dec 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnia (IH) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepiness \[EDS\]). People living with these conditions might find it hard to stay alert and pay attention when they are at school, working, driving, or performing other daily activities. While all conditions result in feeling sleepy, there are some differences in other common symptoms: * NT1: People with NT1 often feel very tired during the day and experience cataplexy. Cataplexy is a sudden loss of muscle strength, which can cause someone to collapse or lose control of their muscles for a short time. This is often triggered by strong emotions, such as laughter or surprise. They may also have trouble sleeping well at night. * NT2: People with NT2 feel sleepy during the day, just like NT1, but they do not have cataplexy. * IH: People with IH feel tired during the day, even after sleeping a lot at night. They may sleep for long periods, take long naps, and find it hard to wake up. Orexin is a protein in the brain that helps coordinate a system that plays an important role in helping people to stay awake during the daytime. Cleminorexton (also known as ORX750) is designed to mimic the action of orexin. The purpose of this study is to see how safe and tolerable ORX750 is in NT1, NT2, and IH, and learn about what the drug does to the body. Another goal of the study is to see if ORX750 can help people with NT1, NT2, and IH feel less sleepy and make other symptoms better.
Conditions
- Narcolepsy Type 1
- Narcolepsy Type 2
- Idiopathic Hypersomnia
Interventions
ORX750Drug
ORX750 capsule.
PlaceboDrug
ORX750 matching placebo capsule.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious TEAEsTime frame: Up to Day 35
- Number of Participants With Abnormal Changes From Baseline in Laboratory TestsTime frame: Up to Day 35
- Number of Participants With Abnormal Change From Baseline in Vital SignsTime frame: Up to Day 35
- Number of Participants With Abnormal Change From Baseline in Electrocardiograms (ECG)Time frame: Up to Day 35
- Number of Participants With Suicidal Ideation or Suicidal Behavior as Measured Using Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: Up to Day 35
Locations
37 sites in 5 countries. Site status is shown where the registry gives one.
Auburn, Alabama
Auburn, Alabama · Recruiting
Chandler, Arizona
Chandler, Arizona · Recruiting
Scottsdale, Arizona
Scottsdale, Arizona · Recruiting
Long Beach, California
Long Beach, California · Recruiting
Santa Ana, California
Santa Ana, California · Recruiting
Brandon, Florida
Brandon, Florida · Recruiting
Miami, Florida
Miami, Florida · Recruiting
Miami, Florida
Miami, Florida · Recruiting
Orlando, FL
Orlando, Florida · Recruiting
Winter Park, Florida
Winter Park, Florida · Recruiting
Atlanta, Georgia
Atlanta, Georgia · Recruiting
Atlanta, Georgia
Atlanta, Georgia · Recruiting
Riverdale, Georgia
Riverdale, Georgia · Recruiting
New Orleans, Louisiana
New Orleans, Louisiana · Recruiting
Newton, Massachusetts
Newton, Massachusetts · Recruiting
Southfield, Michigan
Southfield, Michigan · Recruiting
Sterling Heights, Michigan
Sterling Heights, Michigan · Recruiting
Henderson, Nevada
Henderson, Nevada · Recruiting
Denver, North Carolina
Denver, North Carolina · Recruiting
Huntersville, North Carolina
Huntersville, North Carolina · Recruiting
Cincinnati, Ohio
Cincinnati, Ohio · Recruiting
Cleveland, OH
Cleveland, Ohio · Recruiting
Dublin, Ohio
Dublin, Ohio · Recruiting
Willow Grove, Pennsylvania
Willow Grove, Pennsylvania · Recruiting
Columbia, South Carolina
Columbia, South Carolina · Recruiting
North Charleston, South Carolina
North Charleston, South Carolina · Recruiting
Austin, Texas
Austin, Texas · Recruiting
El Paso, TX
El Paso, Texas · Recruiting
San Antonio, Texas
San Antonio, Texas · Recruiting
Toronto, Ontario
Toronto, Ontario, Canada · Recruiting
Leon, France
Léon, Bordeaux, France · Recruiting
Bologna, Italy
Bologna, Italy · Recruiting
Pozzilli, Italy
Pozzilli, Italy · Recruiting
Verona, Italy
Verona, Italy · Recruiting
Madrid, Spain
Madrid, Spain · Recruiting
Madrid, Spain
Madrid, Spain · Recruiting
Vitoria-Gasteiz, Spain
Vitoria-Gasteiz, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.